Apeloa PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Apeloa PharmaceuticalLtd has a total shareholder equity of CN¥6.5B and total debt of CN¥963.1M, which brings its debt-to-equity ratio to 14.9%. Its total assets and total liabilities are CN¥13.5B and CN¥7.0B respectively. Apeloa PharmaceuticalLtd's EBIT is CN¥1.1B making its interest coverage ratio -14.8. It has cash and short-term investments of CN¥3.7B.
Key information
14.9%
Debt to equity ratio
CN¥963.13m
Debt
Interest coverage ratio | -14.8x |
Cash | CN¥3.72b |
Equity | CN¥6.47b |
Total liabilities | CN¥7.00b |
Total assets | CN¥13.48b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 000739's short term assets (CN¥9.1B) exceed its short term liabilities (CN¥6.8B).
Long Term Liabilities: 000739's short term assets (CN¥9.1B) exceed its long term liabilities (CN¥226.6M).
Debt to Equity History and Analysis
Debt Level: 000739 has more cash than its total debt.
Reducing Debt: 000739's debt to equity ratio has increased from 12.9% to 14.9% over the past 5 years.
Debt Coverage: 000739's debt is well covered by operating cash flow (113%).
Interest Coverage: 000739 earns more interest than it pays, so coverage of interest payments is not a concern.